Evidence map›Paper›PMID 36846489›Full record

ArticleSchizophrenia research. Cognition2023

Association of early life stress and cognitive performance in patients with schizophrenia and healthy controls.

Fanny Senner, Thomas Schneider-Axmann, Lalit Kaurani, Jörg Zimmermann, Jens Wiltfang, Martin von Hagen, Thomas Vogl, Carsten Spitzer, Simon Senner, Eva C Schulte and 23 more

Abstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Digital tools of analysis and data integration facilitate synergy between mouse and human brain research and enable translation.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Fanny SennerDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Thomas Schneider-AxmannDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Lalit KauraniGerman Center of Neurodegenerative Diseases (DZNE), Göttingen 37075, Germany.
Jörg ZimmermannPsychiatrieverbund Oldenburger Land gGmbH, Karl-Jaspers-Klinik, Bad Zwischenahn 26160, Germany.
Jens WiltfangGerman Center of Neurodegenerative Diseases (DZNE), Göttingen 37075, Germany.
Martin von HagenClinic for Psychiatry and Psychotherapy, Clinical Center Werra-Meißner, Eschwege 37269, Germany.
Thomas VoglInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
Carsten SpitzerDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center Rostock, Rostock 18147, Germany.
Simon SennerCenter for Psychiatry Reichenau, Academic Hospital University of Konstanz, Konstanz 78479, Germany.
Eva C SchulteDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Max SchmaußDepartment of Psychiatry and Psychotherapy, Bezirkskrankenhaus Augsburg, Augsburg 86156, Germany.
Sabrina K SchauppInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
Jens ReimerDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
Daniela Reich-ErkelenzInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
Sergi PapiolDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Mojtaba Oraki KohshourInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
Fabian U LangDepartment of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, Günzburg, 89312, Germany.
Carsten KonradDepartment of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, Rotenburg 27356, Germany.
Sophie-Kathrin KirchnerDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Janos L KalmanDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Georg JuckelDepartment of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum 44791, Germany.
Maria HeilbronnerInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
Urs HeilbronnerInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
Christian FiggeKarl-Jaspers Clinic, European Medical School Oldenburg-Groningen, Oldenburg 26160, Germany.
Ruth E EylStuttgart Cancer Center -Tumorzentrum Eva Mayr-Stihl, Klinikum Stuttgart, Stuttgart 70174, Germany.
Detlef DietrichAMEOS Clinical Center Hildesheim, Hildesheim 31135, Germany.
Monika BuddeInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
Ion-George AngelescuDepartment of Psychiatry and Psychotherapy, Mental Health Institute Berlin, Berlin 14050, Germany.
Kristina AdorjanDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Andrea SchmittDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Andre FischerGerman Center of Neurodegenerative Diseases (DZNE), Göttingen 37075, Germany.
Peter FalkaiDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
Thomas G SchulzeInstitute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As core symptoms of schizophrenia, cognitive deficits contribute substantially to poor outcomes. Early life stress (ELS) can negatively affect cognition in patients with schizophrenia and healthy controls, but the exact nature of the mediating factors is unclear. Therefore, we investigated how ELS, education, and symptom burden are related to cognitive performance. The sample comprised 215 patients with schizophrenia (age, 42.9 ± 12.0 years; 66.0 % male) and 197 healthy controls (age, 38.5 ± 16.4 years; 39.3 % male) from the PsyCourse Study. ELS was assessed with the Childhood Trauma Screener (CTS). We used analyses of covariance and correlation analyses to investigate the association of total ELS load and ELS subtypes with cognitive performance. ELS was reported by 52.1 % of patients and 24.9 % of controls. Independent of ELS, cognitive performance on neuropsychological tests was lower in patients than controls (

Indexed as

Cognitive dysfunctionEarly life stressHealthy controlsSchizophrenia

Identifiers

PMID36846489
PMCPMC9945796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.